Wire · regulatory
Ascension's Amsurg deal faces ASC acquisition limits under FTC order
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 25 August 2026 · Fusion42 review
The FTC approved a final consent order requiring Ascension to divest seven ambulatory surgical centers related to its $3.9 billion acquisition of Amsurg, addressing antitrust concerns in multiple US states by limiting Ascension's ASC acquisitions going forward.
This Wire brief sits within Fusion42's coverage of Healthtech Infrastructure, and 2 sources have reported it.
◆ ◆ The Wire takeaway
You must factor in new FTC scrutiny and required divestments when approaching ASC acquisitions—market consolidation just got tougher to execute in outpatient surgery. That tightening opens up divested surgical center customers who could need new partnerships or services.
◆ Coverage
2 sources · 25 Aug 2026
◆ Related on Wire
◆ Topics